2025 Global Biobanking Market Revenue Opportunities Report
Description
The 2025 Global Biobanking Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the global biobanking market are Merck KGaA, Thermo Fisher Scientific Inc., BD (Becton Dickinson and Company), and Lonza. Merck KGaA, headquartered in Germany, offers a broad range of laboratory equipment, reagents, and services for sample collection, storage, and analysis, with a strong emphasis on innovation and sustainability. Thermo Fisher Scientific Inc., based in the U.S., provides comprehensive biobanking solutions including instruments, software, and sample management systems, known for innovation and global support. BD is a leader in medical technology, supplying end-to-end biobanking solutions supporting biological specimen collection, processing, and analysis, aimed at advancing personalized healthcare worldwide. Lonza, also a major player, contributes to biobanking through its specialized life sciences solutions.
These companies operate at the forefront of the biobanking industry, contributing significantly to the growth of this market, which was valued between approximately USD 62 billion to over USD 75 billion in 2023-2024 with expected robust growth rates over the coming decade. Their participation aligns with the increasing demand for personalized medicine, genomic research, and automation in sample handling. North America and Europe are key regions for these companies’ activities owing to advanced healthcare infrastructure and substantial investments in research. Their innovations support the collection, processing, long-term storage, and analysis of biospecimens essential for precision medicine, drug discovery, and disease diagnostics globally.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the global biobanking market are Merck KGaA, Thermo Fisher Scientific Inc., BD (Becton Dickinson and Company), and Lonza. Merck KGaA, headquartered in Germany, offers a broad range of laboratory equipment, reagents, and services for sample collection, storage, and analysis, with a strong emphasis on innovation and sustainability. Thermo Fisher Scientific Inc., based in the U.S., provides comprehensive biobanking solutions including instruments, software, and sample management systems, known for innovation and global support. BD is a leader in medical technology, supplying end-to-end biobanking solutions supporting biological specimen collection, processing, and analysis, aimed at advancing personalized healthcare worldwide. Lonza, also a major player, contributes to biobanking through its specialized life sciences solutions.
These companies operate at the forefront of the biobanking industry, contributing significantly to the growth of this market, which was valued between approximately USD 62 billion to over USD 75 billion in 2023-2024 with expected robust growth rates over the coming decade. Their participation aligns with the increasing demand for personalized medicine, genomic research, and automation in sample handling. North America and Europe are key regions for these companies’ activities owing to advanced healthcare infrastructure and substantial investments in research. Their innovations support the collection, processing, long-term storage, and analysis of biospecimens essential for precision medicine, drug discovery, and disease diagnostics globally.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
